182 related articles for article (PubMed ID: 19592568)
1. The anti-inflammatory agent bindarit inhibits neointima formation in both rats and hyperlipidaemic mice.
Grassia G; Maddaluno M; Guglielmotti A; Mangano G; Biondi G; Maffia P; Ialenti A
Cardiovasc Res; 2009 Dec; 84(3):485-93. PubMed ID: 19592568
[TBL] [Abstract][Full Text] [Related]
2. The herbal extract HMC05 inhibits neointima formation in balloon-injured rat carotid arteries: possible therapeutic implications of HMC05.
Lee JW; Lee BS; Lee JY; Ku HJ; Jeon SR; Kim JY; Ban JM; Sung SH; Shin HM; Park JE
J Ethnopharmacol; 2011 Jan; 133(1):168-76. PubMed ID: 20883768
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of in-stent stenosis by oral administration of bindarit in porcine coronary arteries.
Ialenti A; Grassia G; Gordon P; Maddaluno M; Di Lauro MV; Baker AH; Guglielmotti A; Colombo A; Biondi G; Kennedy S; Maffia P
Arterioscler Thromb Vasc Biol; 2011 Nov; 31(11):2448-54. PubMed ID: 21852559
[TBL] [Abstract][Full Text] [Related]
4. Differential effects of chlorinated and oxidized phospholipids in vascular tissue: implications for neointima formation.
Greig FH; Hutchison L; Spickett CM; Kennedy S
Clin Sci (Lond); 2015 May; 128(9):579-92. PubMed ID: 25524654
[TBL] [Abstract][Full Text] [Related]
5. Bindarit inhibits human coronary artery smooth muscle cell proliferation, migration and phenotypic switching.
Maddaluno M; Grassia G; Di Lauro MV; Parisi A; Maione F; Cicala C; De Filippis D; Iuvone T; Guglielmotti A; Maffia P; Mascolo N; Ialenti A
PLoS One; 2012; 7(10):e47464. PubMed ID: 23077623
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of neointimal hyperplasia in the rat carotid artery injury model by a HMGB1 inhibitor.
Chen J; Zhang J; Xu L; Xu C; Chen S; Yang J; Jiang H
Atherosclerosis; 2012 Oct; 224(2):332-9. PubMed ID: 22857898
[TBL] [Abstract][Full Text] [Related]
7. Deletion of junctional adhesion molecule A from platelets increases early-stage neointima formation after wire injury in hyperlipidemic mice.
Zhao Z; Vajen T; Karshovska E; Dickhout A; Schmitt MM; Megens RTA; von Hundelshausen P; Koeppel TA; Hackeng TM; Weber C; Koenen RR
J Cell Mol Med; 2017 Aug; 21(8):1523-1531. PubMed ID: 28211187
[TBL] [Abstract][Full Text] [Related]
8. MFAP4 Promotes Vascular Smooth Muscle Migration, Proliferation and Accelerates Neointima Formation.
Schlosser A; Pilecki B; Hemstra LE; Kejling K; Kristmannsdottir GB; Wulf-Johansson H; Moeller JB; Füchtbauer EM; Nielsen O; Kirketerp-Møller K; Dubey LK; Hansen PB; Stubbe J; Wrede C; Hegermann J; Ochs M; Rathkolb B; Schrewe A; Bekeredjian R; Wolf E; Gailus-Durner V; Fuchs H; Hrabě de Angelis M; Lindholt JS; Holmskov U; Sorensen GL
Arterioscler Thromb Vasc Biol; 2016 Jan; 36(1):122-33. PubMed ID: 26564819
[TBL] [Abstract][Full Text] [Related]
9. A neutralizing IL-11 antibody reduces vessel hyperplasia in a mouse carotid artery wire injury model.
Schumacher D; Liehn EA; Nilcham P; Mayan DC; Rattanasopa C; Anand K; Crespo-Avilan GE; Hernandez-Resendiz S; Singaraja RR; Cook SA; Hausenloy DJ
Sci Rep; 2021 Oct; 11(1):20674. PubMed ID: 34667238
[TBL] [Abstract][Full Text] [Related]
10. Formononetin protects against balloon injury‑induced neointima formation in rats by regulating proliferation and migration of vascular smooth muscle cells via the TGF‑β1/Smad3 signaling pathway.
Song T; Zhao J; Jiang T; Jin X; Li Y; Liu X
Int J Mol Med; 2018 Oct; 42(4):2155-2162. PubMed ID: 30066831
[TBL] [Abstract][Full Text] [Related]
11. Matrix metalloproteinase-8 promotes vascular smooth muscle cell proliferation and neointima formation.
Xiao Q; Zhang F; Grassia G; Hu Y; Zhang Z; Xing Q; Yin X; Maddaluno M; Drung B; Schmidt B; Maffia P; Ialenti A; Mayr M; Xu Q; Ye S
Arterioscler Thromb Vasc Biol; 2014 Jan; 34(1):90-8. PubMed ID: 24158518
[TBL] [Abstract][Full Text] [Related]
12. Cbx3 inhibits vascular smooth muscle cell proliferation, migration, and neointima formation.
Zhang C; Chen D; Maguire EM; He S; Chen J; An W; Yang M; Afzal TA; Luong LA; Zhang L; Lei H; Wu Q; Xiao Q
Cardiovasc Res; 2018 Mar; 114(3):443-455. PubMed ID: 29206900
[TBL] [Abstract][Full Text] [Related]
13. Intermedin reduces neointima formation by regulating vascular smooth muscle cell phenotype via cAMP/PKA pathway.
Zhu Q; Ni XQ; Lu WW; Zhang JS; Ren JL; Wu D; Chen Y; Zhang LS; Yu YR; Tang CS; Qi YF
Atherosclerosis; 2017 Nov; 266():212-222. PubMed ID: 29053988
[TBL] [Abstract][Full Text] [Related]
14. The I{kappa}B kinase inhibitor nuclear factor-{kappa}B essential modulator-binding domain peptide for inhibition of injury-induced neointimal formation.
Grassia G; Maddaluno M; Musilli C; De Stefano D; Carnuccio R; Di Lauro MV; Parratt CA; Kennedy S; Di Meglio P; Ianaro A; Maffia P; Parenti A; Ialenti A
Arterioscler Thromb Vasc Biol; 2010 Dec; 30(12):2458-66. PubMed ID: 20930169
[TBL] [Abstract][Full Text] [Related]
15. Naringenin inhibits angiotensin II-induced vascular smooth muscle cells proliferation and migration and decreases neointimal hyperplasia in balloon injured rat carotid arteries through suppressing oxidative stress.
Xu C; Chen J; Zhang J; Hu X; Zhou X; Lu Z; Jiang H
Biol Pharm Bull; 2013; 36(10):1549-55. PubMed ID: 23912743
[TBL] [Abstract][Full Text] [Related]
16. The Ca(v)3.1 T-type calcium channel is required for neointimal formation in response to vascular injury in mice.
Tzeng BH; Chen YH; Huang CH; Lin SS; Lee KR; Chen CC
Cardiovasc Res; 2012 Dec; 96(3):533-42. PubMed ID: 22886848
[TBL] [Abstract][Full Text] [Related]
17. Nobiletin Inhibits PDGF-BB-induced vascular smooth muscle cell proliferation and migration and attenuates neointimal hyperplasia in a rat carotid artery injury model.
Guan S; Tang Q; Liu W; Zhu R; Li B
Drug Dev Res; 2014 Dec; 75(8):489-96. PubMed ID: 25452110
[TBL] [Abstract][Full Text] [Related]
18. Cinaciguat prevents neointima formation after arterial injury by decreasing vascular smooth muscle cell migration and proliferation.
Hirschberg K; Tarcea V; Páli S; Barnucz E; Gwanmesia PN; Korkmaz S; Radovits T; Loganathan S; Merkely B; Karck M; Szabó G
Int J Cardiol; 2013 Jul; 167(2):470-7. PubMed ID: 22357420
[TBL] [Abstract][Full Text] [Related]
19. The effect of 2,3,4',5-tetrahydroxystilbene-2-0-β-D glucoside on neointima formation in a rat artery balloon injury model and its possible mechanisms.
Xu XL; Ling DY; Zhu QY; Fan WJ; Zhang W
Eur J Pharmacol; 2013 Jan; 698(1-3):370-8. PubMed ID: 23178522
[TBL] [Abstract][Full Text] [Related]
20. Targeting AGGF1 (angiogenic factor with G patch and FHA domains 1) for Blocking Neointimal Formation After Vascular Injury.
Yao Y; Hu Z; Ye J; Hu C; Song Q; Da X; Yu Y; Li H; Xu C; Chen Q; Wang QK
J Am Heart Assoc; 2017 Jun; 6(6):. PubMed ID: 28649088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
